Reply to letter by Hadigal et al. regarding the cost-effectiveness of high dose quadrivalent vaccine in three European countries

Dear Editor,We thank S. Hadigal and his colleagues from Viatris for their interest in our paper. We are also grateful for the opportunity to address the comments their raised in their letter regard...